• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthMartin Shkreli

Martin Shkreli May Spend 20 Years in Prison

By
Chris Morris
Chris Morris
Former Contributing Writer
Down Arrow Button Icon
By
Chris Morris
Chris Morris
Former Contributing Writer
Down Arrow Button Icon
February 27, 2018, 10:36 AM ET

Martin Shkreli can be held responsible for $10.4 million in losses when he’s sentenced for defrauding investors, meaning the man more commonly known as “Pharma Bro” could face more prison time than he initially expected.

U.S. District Judge Kiyo Matsumoto issued the ruling Monday, saying it did not matter that investors eventually came out ahead since the amount of loss plays a significant role in federal sentencing guidelines.

Shkreli is expected to be sentenced on Mar. 9. He has been in jail since his bail was revoked last September for putting a $5,000 bounty on a strand of Hillary Clinton’s hair. Shkreli and his lawyers were hoping for a prison sentence of 16 months or less. With the decision Monday, though, he could face up to 20 years.

Shkreli was found guilty last August of two counts of securities fraud and one count of conspiracy to commit securities fraud, related to the operations of MSMB Healthcare fund.

Investors, though, did not lose money since Shkreli partly repaid them with Retrophin stock.

Before, during, and after the trial, Shkreli has cultivated a reputation as America’s most hated man, increasing the price of a life-saving drug by 5,000%, holding an anticipated Wu-Tang album hostage, harassing women on Twitter, and for his smug court appearances.

About the Author
By Chris MorrisFormer Contributing Writer

Chris Morris is a former contributing writer at Fortune, covering everything from general business news to the video game and theme park industries.

See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.